Expected to improve operational efficiencies and deliver annual cost savings over $100 million annually “The actions we are taking will further strengthen our core products business and financial ...
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback